Detail page

Knowledge Web

Person

Omar el Bounkari (1970-)

Name	Omar el Bounkari
Time	1970- (Date of birth and death)
Place	Boujniba (Marokko) (Geburtsort) Marokko
Academic degree	Dipl.-Biochem.; Dr. rer. nat.
Variant	Omar El Bounkari
Further information	Diss. Naturwissenschaftliche Fakultät der Univ. Hannover
Record type	Person
GND-Identifier	138585482
Record ID	138585482
Involved in show all Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk An atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis Tissue Inhibitor of Metalloproteinases-1 Interacts with CD74 to Promote AKT Signaling, Monocyte Recruitment Responses, and Vascular Smooth Muscle Cell Proliferation Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting A MIF‐Derived Cyclopeptide that Inhibits MIF Binding and Atherogenic Signaling via the Chemokine Receptor CXCR2 Characterization of Fms interacting protein (FMIP), a novel substrate for tyrosine kinase : connection between receptor tyrosine kinase signaling and mRNA processing Characterization of Fms-interacting protein (FMIP), a novel substrate for tyrosine kinase : connection between receptor tyrosine kinase signaling and mRNA-processing

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Omar el Bounkari (1970-)

Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk

An atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis

Tissue Inhibitor of Metalloproteinases-1 Interacts with CD74 to Promote AKT Signaling, Monocyte Recruitment Responses, and Vascular Smooth Muscle Cell Proliferation

Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation

Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly

Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting

A MIF‐Derived Cyclopeptide that Inhibits MIF Binding and Atherogenic Signaling via the Chemokine Receptor CXCR2

Characterization of Fms interacting protein (FMIP), a novel substrate for tyrosine kinase : connection between receptor tyrosine kinase signaling and mRNA processing

Characterization of Fms-interacting protein (FMIP), a novel substrate for tyrosine kinase : connection between receptor tyrosine kinase signaling and mRNA-processing